4 Best Performing Medical Supply Stocks On SGX [13 Nov 2021] Medtecs (SGX: 546); UG Healthcare (SGX: 8K7); Top Glove (SGX: BVA); Riverstone (SGX: AP4)

It should come as no surprise to any investors that medical supply stocks (along with technology) are among the best-performing stocks around the financial markets in 2021.

As reported within an SGX Market Update on 5 November 2021, 36 out of the 100 most traded stocks this season on the SGX have generated positive returns. Of these 36 stocks, 22 of them have businesses that are related to medical and protective equipment, digitalisation, or work-from-home related electronics.

In this week's edition of four Stocks This Week, we look at some of the best performing medical supply stocks around the SGX in 2021 thus far.

Medtecs International (SGX: 546)

Medtecs is a product manufacturer of a number of medical consumables as well as personal protective equipment, hospital wear, and workwear apparels. It's established a strong presence in america, Europe and Asia Pacific. Due to the COVID-19 pandemic, its services and products have no doubt become essential as countries all over the world continue to cope with the outbreak.

Since the beginning of the year, Medtecs share price has climbed about 22 times from 0.04 to 0.885 (as of 13 Nov). This isn't without good reason. Medtecs reported net profits of US$83.4 million for that first three quarter of 2021, that is a phenomenon return when you consider the company's net profit for FY2021 was US$1.Two million. Net profit margin for the company has also soared from 1.7% in FY2021 to 29.5% so far for the first 9 months of 2021.

Medtecs happens to be the best performing company on the SGX in 2021.

UG Healthcare (SGX: 8K7)

UG Healthcare is predominantly a rubber glove manufacturer that is based in Malaysia. Similar to Medtecs, it's not difficult to imagine why UG Healthcare is probably doing very well in 2021 as the global interest in gloves of all kinds has been in a supernormal level. This may continue for quite a few years even after a COVID-19 vaccine is discovered.

At the beginning of the year, UG Healthcare share price what food was in 0.05. As of 13 November 2021, share price is at 0.76, that is about 15 times higher.

For FY2021 (which ends up on 30 June 2021 for the company), UG Healthcare reported a net profit of S$13.4 million, which is more than 5 times higher compared to its net profit of S$2.5 million in FY2021.

However, more impressively, the organization released on 5 November 2021 its results for 1Q2021. The company saw a revenue of S$71 million for that quarter (1 July 2021 to 30 September 2021) as compared to S$26 million for the same period a year before. Its net profit for the quarter was S$22.6 million, which is already higher than the net profit for the whole of FY2021. Its net profit margin is at 31.9% compared to 1.2% in the same period last year.

Top Glove (SGX: BVA)

Another rubber glove company located in Malaysia, Top Glove is the world's largest manufacturer of gloves with 26% of the world's market share for rubber gloves. Apart from gloves, it has a comprehensive product range including condoms, face masks, dental dams and exercise bands for both healthcare and non-healthcare industries.

In September 2021, Top Glove did a share split when it gave 2 bonus shares for every share held by investors. According to its share split price, the company share price has increased from 0.51 at the beginning of the year to 2.53 as of 13 November 2021, an increase of just about 5 times.

Riverstone Holdings (SGX: AP4)

Riverstone is a leading manufacturer of cleanroom and health care industry consumables, including healthcare gloves, nitrile gloves, finger cots, goggles, packaging materials, and other consumables.

Similar to Top Glove, Riverstone recently did a share split of 1 bonus share for every share held by investors. According to its share split price, the organization share price has increased from 0.47 at the start of the year to 1.52 as of 13 November, a return of approximately 3 times.

Riverstone recently announced its recent results for 3Q2021. As compared to 3Q2021, the company net profit increased by about 400% from RM 35.6 million to RM 178.6 million.

It's important to note that all of the 4 stocks mentioned previously saw its share price decline over the past week when news broke the 2009 week that a COVID-19 vaccine might be ready soon. As such, investors in these companies should tread carefully just like any news of a COVID-19 vaccine (which hopefully will come sooner rather than later), could affect the share prices of these companies.